MENU
PHAR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pharming Group (PHAR) Ownership - Who owns Pharming Group?

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases... Show more

Profile

Industry
N/A
Address
Darwinweg 24
Phone
+31 715247400
Employees
332
Web
https://www.pharming.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
778.38M
P/E Ratio
N/A
Total Cash
126.01M
Projected Growth
N/A
Total Debt
128.33M
Revenue
339.84M
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash/Share
1.84
Total Debt/Equity
N/A
Revenue/Share
4.44 USD as % of share price

Fundamentals

PHAR
Capitalization
778M
P/E Ratio
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash
126M
Total Cash/Share
1.84
Total Debt
128M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.44%
Revenue
340M
ROE
N/A
Book Value
240M
P/B Ratio
3.33
Cash Flow
N/A
Earnings
-0.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.82M
Current Ratio
2.79
Current Revenue Per Employee
230745.05
Dividends Per Share - Security
N/A
EBITDA
29.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.38
Revenue To Assets
-1.90
Shares Held By Institutions
449K
Shares Outstanding - Current
68.5M
Total Liabilities
207M
Total Volume MTD
N/A
Value
-1
Gain YTD
15.748
View a ticker or compare two or three
PHAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHAR showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Darwinweg 24
Phone
+31 715247400
Employees
332
Web
https://www.pharming.com